Sinopharm Group Co Stock | 1099.HK | CNE100000FN7 | A0N99U

Date	Sinopharm Group Co Price
1/8/2025	19.71 undefined
1/7/2025	19.22 undefined
1/6/2025	19.84 undefined
1/3/2025	19.58 undefined
1/2/2025	19.57 undefined
12/31/2024	20.01 undefined
12/30/2024	20.26 undefined
12/27/2024	20.54 undefined
12/24/2024	20.62 undefined
12/23/2024	20.37 undefined
12/20/2024	20.13 undefined
12/19/2024	20.19 undefined
12/18/2024	20.34 undefined
12/17/2024	20.16 undefined
12/16/2024	20.75 undefined
12/13/2024	20.53 undefined
12/12/2024	20.15 undefined
12/11/2024	19.80 undefined
12/10/2024	19.77 undefined

Date	Sinopharm Group Co Revenue	Sinopharm Group Co EBIT	Sinopharm Group Co Net Income
2028e	721.74 B undefined	31.48 B undefined	8.7 B undefined
2027e	695.68 B undefined	29.2 B undefined	8.09 B undefined
2026e	693.56 B undefined	23.24 B undefined	10.06 B undefined
2025e	651.27 B undefined	21.54 B undefined	9.29 B undefined
2024e	612 B undefined	19.98 B undefined	8.55 B undefined
2023	596.57 B undefined	22.28 B undefined	9.05 B undefined
2022	552.15 B undefined	22.54 B undefined	8.53 B undefined
2021	521.05 B undefined	20.84 B undefined	7.76 B undefined
2020	456.41 B undefined	19.03 B undefined	7.19 B undefined
2019	425.27 B undefined	18.09 B undefined	6.25 B undefined
2018	344.53 B undefined	15.75 B undefined	5.84 B undefined
2017	308.35 B undefined	13.14 B undefined	5.58 B undefined
2016	258.39 B undefined	10.21 B undefined	4.65 B undefined
2015	228.67 B undefined	9.23 B undefined	3.77 B undefined
2014	200.13 B undefined	7.86 B undefined	2.87 B undefined
2013	166.87 B undefined	6.1 B undefined	2.25 B undefined
2012	135.79 B undefined	4.86 B undefined	1.97 B undefined
2011	102.23 B undefined	3.64 B undefined	1.56 B undefined
2010	69.23 B undefined	2.41 B undefined	1.21 B undefined
2009	47.05 B undefined	1.55 B undefined	846 M undefined
2008	38.19 B undefined	1.17 B undefined	586 M undefined
2007	31.11 B undefined	789 M undefined	381 M undefined
2006	23.74 B undefined	480 M undefined	101 M undefined

	Revenue	EBIT	Net Income
2006	23.74 B CNY	480 M CNY	101 M CNY
2007	31.11 B CNY	789 M CNY	381 M CNY
2008	38.19 B CNY	1.17 B CNY	586 M CNY
2009	47.05 B CNY	1.55 B CNY	846 M CNY
2010	69.23 B CNY	2.41 B CNY	1.21 B CNY
2011	102.23 B CNY	3.64 B CNY	1.56 B CNY
2012	135.79 B CNY	4.86 B CNY	1.97 B CNY
2013	166.87 B CNY	6.1 B CNY	2.25 B CNY
2014	200.13 B CNY	7.86 B CNY	2.87 B CNY
2015	228.67 B CNY	9.23 B CNY	3.77 B CNY
2016	258.39 B CNY	10.21 B CNY	4.65 B CNY
2017	308.35 B CNY	13.14 B CNY	5.58 B CNY
2018	344.53 B CNY	15.75 B CNY	5.84 B CNY
2019	425.27 B CNY	18.09 B CNY	6.25 B CNY
2020	456.41 B CNY	19.03 B CNY	7.19 B CNY
2021	521.05 B CNY	20.84 B CNY	7.76 B CNY
2022	552.15 B CNY	22.54 B CNY	8.53 B CNY
2023	596.57 B CNY	22.28 B CNY	9.05 B CNY
2024e	612 B CNY	19.98 B CNY	8.55 B CNY
2025e	651.27 B CNY	21.54 B CNY	9.29 B CNY
2026e	693.56 B CNY	23.24 B CNY	10.06 B CNY
2027e	695.68 B CNY	29.2 B CNY	8.09 B CNY
2028e	721.74 B CNY	31.48 B CNY	8.7 B CNY

2006	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023

1.84	1.96	1.71	6.62	7.48	13.1	9.72	14	15.23	19.97	25.58	32.24	40.34	39.19	50.22	43.54	55.33	63.81
4.55	5.58	7.25	9.61	16.19	24.12	34.17	46.9	61.82	58.35	59.76	68.56	96.61	109.5	134.4	159.41	153.28	165.97
0.52	0.8	0.79	3.96	1.85	3.26	3.79	5.77	5.25	8.25	13.02	16.36	13.75	17.07	15.04	16.86	22.45	23.83
2.31	2.9	3.56	4.63	8.46	13.88	15.96	18.83	20.31	22.55	25.76	30.27	35.39	42.59	47.09	51.5	60.93	60.03
0.18	0.72	0.37	0.47	0.88	1.87	2.38	4.22	7.66	8.78	8.64	15.34	18.56	21.65	20.86	19.61	27.42	23.2
9.4	11.96	13.68	25.29	34.86	56.23	66.02	89.71	110.27	117.9	132.76	162.77	204.65	230	267.61	290.92	319.41	336.84
1.09	1.19	1.26	1.45	3.33	4.43	5.38	6.31	7.1	7.64	6.75	9.01	11.03	18.06	18.9	19.41	19.65	19.9
0.33	0.39	0.42	0.48	0.69	0.88	1.07	1.17	1.64	1.85	4.2	6.91	7.65	8.52	9.11	9.77	10.38	11.05
0	0	0	0	0	0	0	0	0	1.55	3.79	0.01	0.01	0.02	0.03	0.01	0.01	0.01
0.15	0.15	0.12	0.2	0.82	1.65	2.15	2.14	2.62	2.72	2.45	2.55	2.58	3.32	3.44	3.19	3.02	3.01
0.03	0.03	0.03	0.12	0.69	2.88	3.4	3.47	3.72	4	3.83	4.7	4.9	5.66	7.29	7.2	7.16	7.19
0.6	0.57	0.61	0.73	1.62	1.55	1.83	2.66	3.29	3.76	3.93	4.74	4.96	4.3	4.86	4.91	5.17	5.41
2.19	2.33	2.43	2.99	7.15	11.4	13.83	15.74	18.38	21.53	24.95	27.92	31.12	39.89	43.63	44.49	45.37	46.56
11.59	14.29	16.12	28.28	42.02	67.63	79.85	105.45	128.66	139.43	157.71	190.69	235.77	269.89	311.24	335.41	364.78	383.39

1.64	1.64	1.64	2.27	2.27	2.4	2.4	2.57	2.77	2.77	2.77	2.77	2.97	2.97	3.12	3.12	3.12	3.12
-0.01	-0.01	-0.01	-0.01	-0.21	-0.23	10.83	13.89	18.08	18.08	18.08	18.08	21.22	21.22	24.64	24.64	24.64	0
0.13	0.05	0.63	8.64	9.64	13.49	3.84	5.35	6.52	9.23	10.94	17.44	18.62	23.21	28.57	34.11	40.29	71.47
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	33.38	37.61	0
5	12	7	16	16	10	10	12	16.69	33.99	30.64	16.59	12.07	15.65	22.66	20.49	17.22	0
1.76	1.68	2.26	10.91	11.71	15.68	17.08	21.82	27.38	30.11	31.81	38.3	42.82	47.42	56.36	95.27	105.68	74.59
5.63	7.21	9.05	12.14	19.83	27.05	34.69	44.19	54.72	59.56	66.75	72.49	83.68	100.33	112.63	128.43	137.09	146.63
0.43	0.45	0.43	0.46	0.6	0.93	1.13	1.58	1.69	2.13	2.65	4.06	4.48	5.4	7.76	8.35	9.57	8.83
0.51	1.76	0.89	0.87	1.98	3.64	3.4	4.06	4.37	5.57	7.98	16.39	21.83	29.02	27.22	25.82	33.67	29.5
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
1.7	1.52	1.5	1.28	3.34	8.67	10.89	21.01	25.23	28.36	22.36	31.65	50.09	43.67	56.37	56.7	54.63	56.53
8.27	10.95	11.88	14.75	25.75	40.29	50.11	70.84	86.02	95.62	99.74	124.58	160.07	178.42	203.98	219.31	234.96	241.49
0.18	0.16	0.13	0.05	0.09	5.18	5.19	4.13	4.22	0.76	11.2	5.59	5.02	11.47	12.16	11.67	14.96	17.25
0.07	0.07	0.06	0.1	0.27	0.52	0.59	0.6	0.63	0.69	0.6	0.85	0.86	1.1	1.11	1.02	0.94	0.79
0.48	0.5	0.63	0.87	1.19	1.25	1.22	1.27	1.49	1.48	1.64	1.72	1.54	1.95	4.04	3.76	3.85	3.54
0.73	0.72	0.83	1.02	1.54	6.95	7	6	6.35	2.93	13.44	8.16	7.42	14.52	17.31	16.45	19.74	21.59
9	11.67	12.71	15.77	27.3	47.24	57.1	76.84	92.37	98.55	113.18	132.75	167.5	192.95	221.29	235.76	254.71	263.08
10.76	13.35	14.97	26.68	39.01	62.92	74.18	98.66	119.75	128.66	144.99	171.05	210.32	240.37	277.65	331.03	360.39	337.66

2006	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022
0.36	0.82	1.08	1.57	2.4	3.13	4.01	4.62	5.93	7.47	8.92	11.23	12.21	13.76	15.6	17	18.56
0.13	0.14	0.17	0.2	0.3	0.46	0.57	0.68	0.84	1.01	1.07	1.24	1.39	3.11	3.6	3.92	4.17
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
-0.05	-0.54	-0.69	-0.74	-1.54	-3.16	-1.58	-2.16	-3.43	3.01	-2.17	-11.19	-13.43	-2.98	-12.38	-16.18	-6.47
0.19	0.02	0.1	-0.02	0.05	0.59	1.02	1.8	2.22	1.93	1.44	1.93	3.48	4.88	4.33	4.56	4.71
0.1	0.14	0.24	0.21	0.31	0.75	1.3	1.6	2.2	1.97	1.99	2.43	4.05	5.18	4.64	4.58	4.78
0.15	0.23	0.3	0.35	0.51	0.83	0.97	1.08	1.39	1.79	2.05	2.73	2.77	3.44	3.66	4.07	4.4
0.64	0.44	0.65	1.01	1.2	1.02	4.02	4.94	5.56	13.41	9.26	3.21	3.65	18.78	11.15	9.31	20.96
-192	-238	-277	-344	-1,444	-1,027	-1,352	-1,211	-1,694	-1,233	-1,363	-2,270	-3,404	-2,548	-2,087	-2,255	-2,417
-271	-14	-148	-3,116	-1,831	-2,831	-2,209	-4,066	-4,357	-1,643	-1,606	-3,159	-5,907	-6,795	-2,202	-1,266	-3,589
-79	224	129	-2,772	-387	-1,804	-856	-2,856	-2,663	-409	-242	-889	-2,503	-4,247	-115	988	-1,172
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
0.04	0.39	-0.72	-0.37	1.16	6.14	-2.7	2.75	-1.18	-3.69	2.33	7.75	14.28	-5.47	6.44	-6.54	2.92
0.31	0	0	8.85	0	2.84	0	3.23	0	0	0	-0.2	0	0.05	3.6	0	0
0.12	-0.31	-0.75	7.01	0.54	7.43	-5.18	3.41	0.02	-7.16	-2.03	3.98	10.32	-13.08	2.03	-14.69	-5.69
-130	-695	99	-391	-603	-1,184	-2,023	-1,919	-2,517	-2,608	-3,217	-2,192	-2,390	-5,913	-6,145	-5,997	-6,273
-101	0	-128	-1,074	-23	-363	-456	-642	-667	-857	-1,134	-1,383	-1,577	-1,753	-1,865	-2,153	-2,340
0.49	0.12	-0.24	4.91	-0.09	5.62	-3.37	4.2	1.23	4.66	5.61	4.04	8.06	-1.11	10.99	-6.65	11.69
446	203	377	668	-241	-8	2,665	3,730	3,866.39	12,178.55	7,894.13	938.2	249.62	16,228.26	9,067.29	7,052.44	18,546.26
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0

Sinopharm Group Co Gross margin	Sinopharm Group Co Profit margin	Sinopharm Group Co EBIT margin	Sinopharm Group Co Profit margin
2028e	8.13 %	4.36 %	1.21 %
2027e	8.13 %	4.2 %	1.16 %
2026e	8.13 %	3.35 %	1.45 %
2025e	8.13 %	3.31 %	1.43 %
2024e	8.13 %	3.27 %	1.4 %
2023	8.13 %	3.73 %	1.52 %
2022	8.59 %	4.08 %	1.54 %
2021	8.45 %	4 %	1.49 %
2020	8.83 %	4.17 %	1.57 %
2019	8.83 %	4.25 %	1.47 %
2018	9.06 %	4.57 %	1.69 %
2017	8.45 %	4.26 %	1.81 %
2016	8 %	3.95 %	1.8 %
2015	8.19 %	4.04 %	1.65 %
2014	8.16 %	3.93 %	1.44 %
2013	8.02 %	3.66 %	1.35 %
2012	8.06 %	3.58 %	1.45 %
2011	8.17 %	3.56 %	1.53 %
2010	8.43 %	3.48 %	1.75 %
2009	8.05 %	3.29 %	1.8 %
2008	7.95 %	3.07 %	1.53 %
2007	8.2 %	2.54 %	1.22 %
2006	8.38 %	2.02 %	0.43 %

	Gross margin	EBIT margin	Profit margin
2006	8.38 %	2.02 %	0.43 %
2007	8.2 %	2.54 %	1.22 %
2008	7.95 %	3.07 %	1.53 %
2009	8.05 %	3.29 %	1.8 %
2010	8.43 %	3.48 %	1.75 %
2011	8.17 %	3.56 %	1.53 %
2012	8.06 %	3.58 %	1.45 %
2013	8.02 %	3.66 %	1.35 %
2014	8.16 %	3.93 %	1.44 %
2015	8.19 %	4.04 %	1.65 %
2016	8 %	3.95 %	1.8 %
2017	8.45 %	4.26 %	1.81 %
2018	9.06 %	4.57 %	1.69 %
2019	8.83 %	4.25 %	1.47 %
2020	8.83 %	4.17 %	1.57 %
2021	8.45 %	4 %	1.49 %
2022	8.59 %	4.08 %	1.54 %
2023	8.13 %	3.73 %	1.52 %
2024e	8.13 %	3.27 %	1.4 %
2025e	8.13 %	3.31 %	1.43 %
2026e	8.13 %	3.35 %	1.45 %
2027e	8.13 %	4.2 %	1.16 %
2028e	8.13 %	4.36 %	1.21 %

Date	Sinopharm Group Co Sales per Share	Sinopharm Group Co EBIT per share	Sinopharm Group Co Earnings per Share
2028e	231.28 undefined	0 undefined	2.79 undefined
2027e	222.93 undefined	0 undefined	2.59 undefined
2026e	222.25 undefined	0 undefined	3.22 undefined
2025e	208.7 undefined	0 undefined	2.98 undefined
2024e	196.11 undefined	0 undefined	2.74 undefined
2023	191.17 undefined	7.14 undefined	2.9 undefined
2022	176.93 undefined	7.22 undefined	2.73 undefined
2021	166.97 undefined	6.68 undefined	2.49 undefined
2020	146.7 undefined	6.12 undefined	2.31 undefined
2019	143.21 undefined	6.09 undefined	2.11 undefined
2018	115.94 undefined	5.3 undefined	1.96 undefined
2017	103.76 undefined	4.42 undefined	1.88 undefined
2016	93.38 undefined	3.69 undefined	1.68 undefined
2015	82.64 undefined	3.33 undefined	1.36 undefined
2014	77.41 undefined	3.04 undefined	1.11 undefined
2013	66.14 undefined	2.42 undefined	0.89 undefined
2012	56.51 undefined	2.02 undefined	0.82 undefined
2011	43.39 undefined	1.54 undefined	0.66 undefined
2010	30.57 undefined	1.06 undefined	0.53 undefined
2009	26.01 undefined	0.86 undefined	0.47 undefined
2008	23.33 undefined	0.72 undefined	0.36 undefined
2007	19 undefined	0.48 undefined	0.23 undefined
2006	14.5 undefined	0.29 undefined	0.06 undefined

	Sales per Share	EBIT per share	Earnings per Share
2006	14.5 CNY	0.29 CNY	0.06 CNY
2007	19 CNY	0.48 CNY	0.23 CNY
2008	23.33 CNY	0.72 CNY	0.36 CNY
2009	26.01 CNY	0.86 CNY	0.47 CNY
2010	30.57 CNY	1.06 CNY	0.53 CNY
2011	43.39 CNY	1.54 CNY	0.66 CNY
2012	56.51 CNY	2.02 CNY	0.82 CNY
2013	66.14 CNY	2.42 CNY	0.89 CNY
2014	77.41 CNY	3.04 CNY	1.11 CNY
2015	82.64 CNY	3.33 CNY	1.36 CNY
2016	93.38 CNY	3.69 CNY	1.68 CNY
2017	103.76 CNY	4.42 CNY	1.88 CNY
2018	115.94 CNY	5.3 CNY	1.96 CNY
2019	143.21 CNY	6.09 CNY	2.11 CNY
2020	146.7 CNY	6.12 CNY	2.31 CNY
2021	166.97 CNY	6.68 CNY	2.49 CNY
2022	176.93 CNY	7.22 CNY	2.73 CNY
2023	191.17 CNY	7.14 CNY	2.9 CNY
2024e	196.11 CNY	0 CNY	2.74 CNY
2025e	208.7 CNY	0 CNY	2.98 CNY
2026e	222.25 CNY	0 CNY	3.22 CNY
2027e	222.93 CNY	0 CNY	2.59 CNY
2028e	231.28 CNY	0 CNY	2.79 CNY

	Number of stocks
2006	1.64 B Aktien
2007	1.64 B Aktien
2008	1.64 B Aktien
2009	1.81 B Aktien
2010	2.27 B Aktien
2011	2.36 B Aktien
2012	2.4 B Aktien
2013	2.52 B Aktien
2014	2.59 B Aktien
2015	2.77 B Aktien
2016	2.77 B Aktien
2017	2.97 B Aktien
2018	2.97 B Aktien
2019	2.97 B Aktien
2020	3.11 B Aktien
2021	3.12 B Aktien
2022	3.12 B Aktien
2023	3.12 B Aktien
2024e	3.12 B Aktien
2025e	3.12 B Aktien
2026e	3.12 B Aktien
2027e	3.12 B Aktien
2028e	3.12 B Aktien

Date	Sinopharm Group Co Dividend
2028e	0.98 undefined
2027e	0.98 undefined
2026e	0.98 undefined
2025e	0.98 undefined
2024e	0.98 undefined
2023	0.9 undefined
2022	0.87 undefined
2021	0.84 undefined
2020	0.65 undefined
2019	0.67 undefined
2018	0.69 undefined
2017	0.57 undefined
2016	0.48 undefined
2015	0.31 undefined
2014	0.26 undefined
2013	0.25 undefined
2012	0.19 undefined
2011	0.16 undefined
2010	0.01 undefined

	Dividend	Dividend (Estimate)
2006	0 CNY	0 CNY
2007	0 CNY	0 CNY
2008	0 CNY	0 CNY
2009	0 CNY	0 CNY
2010	0.01 CNY	0 CNY
2011	0.16 CNY	0 CNY
2012	0.19 CNY	0 CNY
2013	0.25 CNY	0 CNY
2014	0.26 CNY	0 CNY
2015	0.31 CNY	0 CNY
2016	0.48 CNY	0 CNY
2017	0.57 CNY	0 CNY
2018	0.69 CNY	0 CNY
2019	0.67 CNY	0 CNY
2020	0.65 CNY	0 CNY
2021	0.84 CNY	0 CNY
2022	0.87 CNY	0 CNY
2023	0.9 CNY	0 CNY
2024e	0 CNY	0.98 CNY
2025e	0 CNY	0.98 CNY
2026e	0 CNY	0.98 CNY
2027e	0 CNY	0.98 CNY
2028e	0 CNY	0.98 CNY

Date	Sinopharm Group Co Payout ratio
2028e	31.89 %
2027e	32 %
2026e	31.83 %
2025e	31.85 %
2024e	32.33 %
2023	31.3 %
2022	31.92 %
2021	33.76 %
2020	28.23 %
2019	31.89 %
2018	34.98 %
2017	30.51 %
2016	28.72 %
2015	22.74 %
2014	23.38 %
2013	28.09 %
2012	23.17 %
2011	24.24 %
2010	1.91 %
2009	31.3 %
2008	31.3 %
2007	31.3 %
2006	31.3 %

	Payout ratio
2006	31.3 %
2007	31.3 %
2008	31.3 %
2009	31.3 %
2010	1.91 %
2011	24.24 %
2012	23.17 %
2013	28.09 %
2014	23.38 %
2015	22.74 %
2016	28.72 %
2017	30.51 %
2018	34.98 %
2019	31.89 %
2020	28.23 %
2021	33.76 %
2022	31.92 %
2023	31.3 %
2024e	32.33 %
2025e	31.85 %
2026e	31.83 %
2027e	32 %
2028e	31.89 %

Date	EPS Estimate	EPS Actual	Quarterly report
6/30/2024	1.41	1.34 (-4.8 %)	2024 Q2
12/31/2023	1.54	1.58 (2.58 %)	2023 Q4
6/30/2023	1.37	1.32 (-3.42 %)	2023 Q2
12/31/2022	1.46	2.55 (74.83 %)	2022 Q4
6/30/2022	1.26	0.18 (-85.77 %)	2022 Q2
12/31/2021	1.5	1.34 (-10.63 %)	2021 Q4
6/30/2021	1.06	1.15 (8.41 %)	2021 Q2
12/31/2020	1.4	1.38 (-1.25 %)	2020 Q4
6/30/2020	1	0.93 (-6.96 %)	2020 Q2
12/31/2019	1.25	1.1 (-12.32 %)	2019 Q4
6/30/2019	1.14	1 (-12.47 %)	2019 Q2
12/31/2018	1.42	0.99 (-30.19 %)	2018 Q4
6/30/2018	0.95	0.97 (2.26 %)	2018 Q2
12/31/2017	0.8	0.91 (13.65 %)	2017 Q4
6/30/2017	0.95	1 (4.85 %)	2017 Q2
12/31/2016	0.78	0.77 (-0.67 %)	2016 Q4
6/30/2016	0.81	0.91 (12.93 %)	2016 Q2
12/31/2015	0.67	0.67 (-0.48 %)	2015 Q4
6/30/2015	0.65	0.69 (5.7 %)	2015 Q2
6/30/2014	0.54	0.57 (5.44 %)	2014 Q2
12/31/2013	0.44	0.43 (-1.96 %)	2013 Q4
6/30/2013	0.47	0.46 (-1.96 %)	2013 Q2
12/31/2012	0.39	0.42 (6.95 %)	2012 Q4
12/31/2011	0.37	0.32 (-14.51 %)	2011 Q4
6/30/2011	0.39	0.34 (-12.05 %)	2011 Q2
12/31/2010	0.31	0.25 (-20.43 %)	2010 Q4
6/30/2010	0.29	0.28 (-4.34 %)	2010 Q2

%	Name	Stocks	Change	Date
3.67545 %	Lazard Asset Management, L.L.C.	114,698,209	13,863,175	9/20/2024
3.65920 %	Fidelity Management & Research Company LLC	114,191,174	-15,208,564	9/24/2024
1.82520 %	JPMorgan Asset Management (Asia Pacific) Limited	56,958,400	510,000	10/16/2024
1.35159 %	The Vanguard Group, Inc.	42,178,462	201,600	9/30/2024
1.31798 %	BlackRock Institutional Trust Company, N.A.	41,129,749	-2,617,600	8/2/2024
0.93888 %	Fidelity Institutional Asset Management	29,299,220	3,679,480	9/24/2024
0.80207 %	Dimensional Fund Advisors, L.P.	25,030,000	31,600	9/30/2024
0.70020 %	Fidelity Management & Research (Hong Kong) Limited	21,850,899	0	8/31/2024
0.68725 %	Bosera Asset Management Co., Ltd.	21,446,800	-77,600	6/30/2024
0.68577 %	Hang Seng Investment Management Ltd.	21,400,598	587,393	9/30/2024
0.58399 %	BlackRock Asset Management Ireland Limited	18,224,370	873,374	8/2/2024
0.54569 %	Fidelity Investments Canada ULC	17,029,200	1,426,000	9/17/2024
0.52593 %	Norges Bank Investment Management (NBIM)	16,412,336	-3,396,331	6/30/2024
0.48430 %	State Street Global Advisors Asia Ltd.	15,113,378	59,211	10/31/2023
0.45829 %	BlackRock Advisors (UK) Limited	14,301,795	314,800	9/30/2024
0.44819 %	Swedbank Robur Fonder AB	13,986,463	0	9/30/2024
0.44714 %	Value Partners Ltd.	13,953,600	-3,198,800	6/30/2024
0.42412 %	JPMorgan Asset Management U.K. Limited	13,235,200	700,000	10/16/2024
0.41344 %	JP Morgan Asset Management	12,901,972	833,396	10/16/2024
0.36278 %	Geode Capital Management, L.L.C.	11,321,199	0	9/30/2024
0.32890 %	Nordea Investment Management AB (Denmark)	10,264,000	-198,400	9/30/2024
0.31036 %	JPMorgan Asset Management (Taiwan) Limited	9,685,200	0	9/30/2024
0.29704 %	Charles Schwab Investment Management, Inc.	9,269,689	814,874	9/30/2024
0.28638 %	California State Teachers Retirement System	8,936,831	808,349	6/30/2023
0.28074 %	California Public Employees' Retirement System	8,760,948	-1,167,600	6/30/2023
0.25042 %	Florida State Board of Administration	7,814,800	495,200	6/30/2024
0.22822 %	State Street Global Advisors (US)	7,121,966	96,588	9/30/2024
0.22464 %	China Asset Management Co., Ltd.	7,010,400	1,042,000	6/30/2024
0.22163 %	Fidelity Management Trust Company	6,916,355	6,916,355	9/24/2024
0.20539 %	BlackRock (Netherlands) B.V.	6,409,461	-1,017,786	3/17/2023
0.18009 %	Yinhua Fund Management Co., Ltd.	5,620,000	5,092,000	6/30/2024
0.17819 %	Bin Yuan Capital Limited	5,560,753	517,200	3/31/2024
0.16840 %	Zhong Ou Asset Management Co., Ltd.	5,255,200	5,255,200	6/30/2024
0.15920 %	BlackRock Investment Management (UK) Ltd.	4,968,193	125,947	8/2/2024
0.15547 %	Principal Global Investors (Hong Kong) Limited	4,851,600	43,600	12/31/2023
0.13665 %	Guotai Asset Management Co., Ltd.	4,264,388	-569,982	6/30/2024
0.13550 %	Nordea Funds Oy	4,228,400	0	7/31/2024
0.12617 %	Robeco Institutional Asset Management B.V.	3,937,429	-158,135	9/30/2024
0.12200 %	Kopernik Global Investors, LLC	3,807,200	0	8/31/2024
0.12163 %	Dimensional Fund Advisors, Ltd.	3,795,600	57,200	9/30/2024
0.12153 %	APG Asset Management N.V.	3,792,565	-3,134,068	12/31/2023
0.11892 %	Research Affiliates, LLC	3,711,200	0	3/31/2024
0.11362 %	Z¿rcher Kantonalbank (Asset Management)	3,545,672	-1,663,200	9/30/2024
0.10494 %	Allspring Global Investments, LLC	3,274,800	0	9/30/2024
0.09953 %	E Fund Management Co. Ltd.	3,106,000	34,800	6/30/2024
0.09607 %	American Century Investment Management, Inc.	2,998,000	18,000	6/30/2024
0.09513 %	Amundi Asset Management, SAS	2,968,800	-36,400	9/30/2024
0.09445 %	Lazard Asset Management Limited	2,947,600	-96,400	8/31/2024
0.09160 %	Royal London Asset Management Ltd.	2,858,400	357,600	6/30/2024
0.08883 %	UBS Asset Management (UK) Ltd.	2,772,094	52,400	9/30/2024
0.08338 %	China Asset Management (Hong Kong) Limited	2,601,955	-488,673	9/30/2024
0.08146 %	China Merchants Fund Management Co. Ltd.	2,542,000	827,200	6/30/2024
0.07481 %	Aviva Investors Global Services Limited	2,334,485	-1,287	9/30/2024
0.07424 %	State Street Global Advisors Ireland Limited	2,316,653	-12,400	9/30/2024
0.07124 %	BlackRock (Singapore) Limited	2,223,055	-24,888	9/30/2024
0.06922 %	Eastspring Investments (Singapore) Limited	2,160,000	0	9/30/2024
0.06634 %	China Southern Asset Management Co. Ltd.	2,070,400	1,120,700	6/30/2024
0.06608 %	PGGM Vermogensbeheer B.V.	2,061,983	-103,349	7/31/2024
0.06577 %	Causeway Capital Management LLC	2,052,400	221,200	6/30/2024
0.06364 %	UBS Fund Management (Switzerland) AG	1,986,000	-19,600	9/30/2024
0.06310 %	Nuveen LLC	1,968,987	82,000	8/31/2024
0.06272 %	JPMorgan Asset Management (China) Company Limited.	1,957,200	1,737,600	6/30/2024
0.06088 %	OrbiMed Advisors, LLC	1,900,000	682,300	6/30/2024
0.06078 %	ICBC Credit Suisse Asset Management Co. Ltd.	1,896,800	1,896,800	6/30/2024
0.05973 %	Bessemer Trust Company, N.A. (US)	1,864,000	0	7/31/2024
0.05969 %	State Street Global Advisors (UK) Ltd.	1,862,572	28,400	9/30/2024
0.05817 %	MFS Investment Management	1,815,200	2,400	9/30/2024
0.05496 %	Northern Trust Global Investments Limited	1,715,035	-35,200	8/31/2024
0.05377 %	Storebrand Kapitalforvaltning AS	1,678,000	0	9/30/2024
0.05166 %	DWS Investment GmbH	1,612,141	-34,841	9/30/2024
0.05122 %	Wellington Management Company, LLP	1,598,287	-2,567	8/31/2024
0.04964 %	Penghua Fund Management Co., Ltd.	1,549,200	122,400	6/30/2024
0.04653 %	DWS Investments UK Limited	1,452,164	-13,505	9/30/2024
0.04635 %	Lazard Frères Gestion S.A.S.	1,446,538	242,800	9/30/2024
0.04335 %	UBS Asset Management (Switzerland)	1,352,800	0	8/31/2024
0.03840 %	HSBC Global Asset Management (UK) Limited	1,198,184	9,843	9/30/2024
0.03833 %	Dodge & Cox	1,196,000	0	9/30/2024
0.03812 %	Bellevue Asset Management AG	1,189,600	0	9/30/2024
0.03743 %	Matthews International Capital Management, L.L.C.	1,168,000	-1,600	8/31/2024
0.03694 %	Amundi Japan Ltd.	1,152,800	0	9/30/2024
0.03515 %	Union Investment Luxembourg S.A.	1,096,939	0	6/30/2024
0.03399 %	Fullgoal Fund Management Co., Ltd.	1,060,800	-1,719,600	6/30/2024
0.03225 %	Nykredit Bank AS	1,006,401	64,000	9/30/2024
0.03204 %	Bank of Singapore Limited	1,000,000	0	7/31/2023
0.03187 %	EARNEST Partners, LLC	994,400	98,000	6/30/2024
0.03128 %	INVESCO Great Wall Fund Management Co. Ltd.	976,000	966,400	6/30/2024
0.03126 %	Pictet Asset Management Ltd.	975,400	0	7/31/2024
0.03071 %	Caisse de Depot et Placement du Quebec	958,502	698,879	12/31/2023
0.02975 %	abrdn Alternative Investments Limited	928,400	0	8/31/2024
0.02916 %	BOCI-Prudential Asset Management Ltd.	910,000	0	6/30/2024
0.02907 %	Tianhong Asset Management Co., Ltd.	907,200	-1,015,200	6/30/2024
0.02884 %	Lion Global Investors Limited	900,000	-300,000	12/31/2023
0.02830 %	Mercer Global Investments Management Ltd	883,200	0	3/31/2024
0.02801 %	Grantham Mayo Van Otterloo & Co LLC	874,048	-115,600	5/31/2024
0.02788 %	Asia Growth Capital Management AB	870,000	-240,000	9/30/2023
0.02542 %	Polunin Capital Partners Limited	793,200	-165,600	12/31/2023
0.02516 %	CIBC Asset Management Inc.	785,075	0	6/30/2024
0.02494 %	First Trust Advisors L.P.	778,294	-326	8/31/2024
0.02339 %	UBS Asset Management (Americas), Inc.	730,000	7,600	6/30/2024
0.02325 %	ID-Sparinvest A/S	725,600	160,800	9/30/2024

Name	Relationship	Two-week correlation	One-month correlation	Three-Month Correlation	Six-Month Correlation	One Year Correlation	Two-Year Correlation
Metsa Board B	SupplierCustomer	0,93	0,43	-0,34	0,13	0,06	0,27
Basler	SupplierCustomer	0,55	-0,17	0,20	-0,54	-0,34	0,12
Zhejiang Jiuzhou Pharm A	SupplierCustomer	0,54	0,37	-0,44	-0,59	-0,46	0,06
China National Medicines A	SupplierCustomer	0,50	0,40	0,16	-0,18	0,75	-0,12
SciClone Pharmaceuticals	SupplierCustomer	0,45	0,53	0,17	-0,09	0,89
Shanghai Fosun Pharm H	SupplierCustomer	0,36	0,59	-0,15	-0,12	0,79	0,70
BeiGene	SupplierCustomer	0,23	0,43	0,72	-0,18	0,49	0,35
Shanxi Zhendong A	SupplierCustomer	0,20	0,46	-0,55	0,01	-0,50	-0,22
Oramed Pharmaceuticals	SupplierCustomer	-0,20	0,43	0,64	-0,16	0,09	0,24
China National Accord A	SupplierCustomer	-0,25	0,22	0,53	0,11	0,80	-0,01

What values and corporate philosophy does Sinopharm Group Co represent?

Sinopharm Group Co Ltd represents the values of integrity, innovation, and excellence. The company is guided by a corporate philosophy that prioritizes customer-centricity and social responsibility. With a focus on healthcare, Sinopharm Group Co Ltd strives to provide high-quality medical products and services to people worldwide. Through continuous research and development, they aim to improve healthcare access and enhance well-being. By upholding its values and corporate philosophy, Sinopharm Group Co Ltd actively contributes to the advancement of the global healthcare industry, making a positive impact on people's lives.

In which countries and regions is Sinopharm Group Co primarily present?

Sinopharm Group Co Ltd is primarily present in China.

What significant milestones has the company Sinopharm Group Co achieved?

Sinopharm Group Co Ltd has achieved several significant milestones throughout its history. One notable accomplishment is the company's successful listing on the Hong Kong stock exchange in 2009, followed by its inclusion in the Hang Seng Index in 2011. Sinopharm has also made significant advancements in the healthcare industry, expanding its portfolio through acquisitions and strategic collaborations. Notably, the company established Sinopharm Holding Guoda Drugstore, an integrated pharmaceutical retailer. In addition, Sinopharm is at the forefront of medical research and development, collaborating with international pharmaceutical companies and contributing to the innovation of new drugs. Sinopharm Group Co Ltd continues to strive for excellence and cement its position as a leading global healthcare company.

What is the history and background of the company Sinopharm Group Co?

Sinopharm Group Co Ltd, a renowned pharmaceutical and healthcare company, has a rich history and stellar background. Established in 2003, Sinopharm has emerged as a leading player in the healthcare industry. It operates in various segments, including distribution, retail, manufacturing, research, and more. With headquarters in Beijing, China, Sinopharm has focused on expanding its operations globally, establishing a presence across 150 countries. The company strives to improve healthcare accessibility and quality by offering a wide range of products and services, including pharmaceuticals, medical devices, and healthcare solutions. Sinopharm Group Co Ltd's commitment to innovation, quality, and professionalism has earned it a strong reputation in the global market.

Who are the main competitors of Sinopharm Group Co in the market?

The main competitors of Sinopharm Group Co Ltd in the market are Shanghai Fosun Pharmaceutical Group Co Ltd, China Resources Pharmaceutical Group Ltd, and CSPC Pharmaceutical Group Ltd.

In which industries is Sinopharm Group Co primarily active?

Sinopharm Group Co Ltd is primarily active in the healthcare industry.

What is the business model of Sinopharm Group Co?

The business model of Sinopharm Group Co Ltd focuses on providing pharmaceutical and healthcare products and services. Sinopharm Group operates through various segments, including Distribution, Retail Pharmacy, Pharmaceutical Manufacturing, and others. As China's largest pharmaceutical distribution and retail company, Sinopharm Group plays a crucial role in the healthcare industry. The company offers a wide range of products, including prescription drugs, over-the-counter medicines, medical devices, and healthcare services. Sinopharm Group aims to enhance the accessibility and affordability of quality healthcare by ensuring the efficient supply chain and expanding its reach across different regions in China.

What is the P/E ratio of Sinopharm Group Co 2025?

The Sinopharm Group Co P/E ratio is 6.62.

What is the P/S ratio of Sinopharm Group Co 2025?

The Sinopharm Group Co P/S ratio is 0.09.

What is the Quality Investing of Sinopharm Group Co?

The Quality Investing for Sinopharm Group Co is 9/10.

What is the revenue of Sinopharm Group Co 2025?

The expected Sinopharm Group Co revenue is 651.27 B CNY.

How high is the profit of Sinopharm Group Co 2025?

The expected Sinopharm Group Co profit is 9.29 B CNY.

What is the business model of Sinopharm Group Co

Sinopharm Group Co Ltd is a leading Chinese company specializing in the manufacturing and marketing of pharmaceutical products, medical devices, vaccines, health products, and services. The company covers a wide range of business areas, including the production of medicines, vaccines, medical devices, and medical services. It focuses on customizing its offerings to meet the needs of end customers, establishing itself as a strong player in the global market. The company's main emphasis is on the production and marketing of pharmaceutical products, including a wide range of medicines and medical devices such as eye drops, cough and cold medicines, vitamins and minerals, painkillers, antibiotics, and cancer therapeutics. Sinopharm Group Co Ltd is also a leading provider of vaccines, producing and distributing a broad range of vaccines including those for Hepatitis B, rabies, measles, mumps, and rubella. Additionally, the company offers health products like dietary supplements, diagnostic devices, and medical accessories. It also develops and manufactures medical devices such as urinary catheters, implants, and stents. In addition to these areas, Sinopharm Group Co Ltd is also involved in other segments of the healthcare industry such as hospital management and medical services. It operates a chain of hospitals and pharmacies in China, providing medical services such as consultations, diagnoses, prevention, and rehabilitation. The company's business model is focused on offering products and services tailored to the needs and demands of customers. It invests in research and development to create innovative and cost-effective products and solutions.

What is the Sinopharm Group Co dividend?

Sinopharm Group Co pays a dividend of 0.87 CNY distributed over payouts per year.

How often does Sinopharm Group Co pay dividends?

The dividend cannot currently be calculated for Sinopharm Group Co or the company does not pay out a dividend.

What is the Sinopharm Group Co ISIN?

The ISIN of Sinopharm Group Co is CNE100000FN7.

What is the Sinopharm Group Co WKN?

The WKN of Sinopharm Group Co is A0N99U.

What is the Sinopharm Group Co ticker?

The ticker of Sinopharm Group Co is 1099.HK.

How much dividend does Sinopharm Group Co pay?

Over the past 12 months, Sinopharm Group Co paid a dividend of 0.9 CNY . This corresponds to a dividend yield of about 4.57 %. For the coming 12 months, Sinopharm Group Co is expected to pay a dividend of 0.98 CNY.

What is the dividend yield of Sinopharm Group Co?

The current dividend yield of Sinopharm Group Co is 4.57 %.

When does Sinopharm Group Co pay dividends?

Sinopharm Group Co pays a quarterly dividend. This is distributed in the months of July, July, July, July.

How secure is the dividend of Sinopharm Group Co?

Sinopharm Group Co paid dividends every year for the past 19 years.

What is the dividend of Sinopharm Group Co?

For the upcoming 12 months, dividends amounting to 0.98 CNY are expected. This corresponds to a dividend yield of 5.08 %.

In which sector is Sinopharm Group Co located?

Sinopharm Group Co is assigned to the 'Health' sector.

Wann musste ich die Aktien von Sinopharm Group Co kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Sinopharm Group Co from 8/13/2024 amounting to 0.956 CNY, you needed to have the stock in your portfolio before the ex-date on 6/17/2024.

When did Sinopharm Group Co pay the last dividend?

The last dividend was paid out on 8/13/2024.

What was the dividend of Sinopharm Group Co in the year 2024?

In the year 2024, Sinopharm Group Co distributed 0.9 CNY as dividends.

In which currency does Sinopharm Group Co pay out the dividend?

The dividends of Sinopharm Group Co are distributed in CNY.

Scope 1 - Direct Emissions	52,434.34
Scope 2 - Indirect emissions from purchased energy	200,670.94
Scope 3 - Indirect emissions within the value chain
Total CO₂ emissions	253,105.28
CO₂ reduction strategy
Coal energy
Nuclear power
Animal experiments
Fur & Leather
Pesticides
Palm Oil
Tobacco
Genetically modified organisms
Climate concept
Sustainable forestry
Recycling regulations
Environmentally friendly packaging
Hazardous substances
Fuel consumption and efficiency
Water consumption and efficiency

Percentage of female employees	62.18
Percentage of women in management
Percentage of Asian employees
Share of Asian management
Percentage of Hispanic/Latino employees
Hispano/Latino Management share
Percentage of Black employees
Black Management Share
Percentage of white employees
White Management Share
Adult content
Alcohol
Weapons
Firearms
Gambling
Military contracts
Human rights concept
Privacy concept
Occupational health and safety
Catholic

Environmental reporting
Stakeholder Engagement
Call Back Policies
Antitrust law

Stock Exchange	Sinopharm Group Co Ticker
DÜSSELDORF	X2S.DU
FRANKFURT	X2S.F
HKSE	1099.HK
MUNICH	X2S.MU
PNK	SHTDF

Sinopharm Group Co Ticker	Sinopharm Group Co FIGI
X2S:TH	BBG000DNDW63
1099:HK	BBG000VWV3Z5
X2S:GR	BBG000VZC4Y8
X2S:GF	BBG000VZC5B0
X2S:GD	BBG000VZC5G5
X2S:GS	BBG000VZC5T1
X2S:GM	BBG000VZC619
X2S:GB	BBG000VZC673
SHTDF:US	BBG000W3LVW0
SHTDF:PQ	BBG000W3LY63
SHTDF:UV	BBG000W3LYT8
1099:H1	BBG006Z3JRY4
X2S:QT	BBG008VHZWG4
1099EUR:EO	BBG008VJH962
1099EUR:XH	BBG008VJH9C5
1099EUR:XF	BBG008VJH9H0
1099EUR:XE	BBG008VJH9L5
1099EUR:XJ	BBG008VJH9N3
1099EUR:XL	BBG008VJH9Q0
1099EUR:XG	BBG008VJH9R9
1099EUR:XO	BBG008VJH9T7
1099EUR:XS	BBG008VJHB12
1099EUR:XA	BBG008VJHB30
1099EUR:E1	BBG008VJHB58
1099EUR:XT	BBG008VJHB76
1099EUR:XW	BBG008VJHB85
1099EUR:XU	BBG008VJHBB1
1099EUR:XV	BBG008VJHBF7
1099EUR:EU	BBG008VJHCZ3
1099:H2	BBG00F1359F7
X2S:GZ	BBG00FGWJSV2
1099EUR:XX	BBG00JN8DSP2
1099N:PO	BBG00JRFW6Q8
1099N:S2	BBG00JRFYN43
1099N:L3	BBG00JRG1G51
1099N:B3	BBG00JRG4LG5
1099HKD:X2	BBG00JRGGWW0
1099HKD:XB	BBG00JRGGWX9
1099HKD:XH	BBG00JRGGWZ7
1099HKD:XF	BBG00JRGGX12
1099HKD:XE	BBG00JRGGX30
1099HKD:XJ	BBG00JRGGX49
1099HKD:XL	BBG00JRGGX58
1099HKD:XG	BBG00JRGGX67
1099HKD:XO	BBG00JRGGX76
1099HKD:XS	BBG00JRGGXC0
1099HKD:XA	BBG00JRGGXD9
1099HKD:E1	BBG00JRGGXF7
1099HKD:XT	BBG00JRGGXG6
1099HKD:XW	BBG00JRGGXH5
1099HKD:XU	BBG00JRGGXJ3
1099HKD:XV	BBG00JRGGXK1
1099HKD:XM	BBG00JRGGXL0
1099HKD:XQ	BBG00JRGGXN8
1099HKD:XX	BBG00JRGGXP6
1099HKD:XZ	BBG00JRGGXQ5
1099HKD:EU	BBG00JRGGXS3
1099N:L1	BBG00Y7B0RH5
X2S:LA	BBG018H91H77
X2S:LU	BBG018J2PJ34

2006	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024e	2025e	2026e	2027e	2028e
23.74	31.11	38.19	47.05	69.23	102.23	135.79	166.87	200.13	228.67	258.39	308.35	344.53	425.27	456.42	521.05	552.15	596.57	612	651.27	693.56	695.68	721.74
-	31.06	22.75	23.20	47.16	47.65	32.83	22.89	19.94	14.26	12.99	19.34	11.73	23.44	7.32	14.16	5.97	8.05	2.59	6.42	6.49	0.30	3.75
8.38	8.20	7.95	8.05	8.43	8.17	8.06	8.02	8.16	8.19	8.00	8.45	9.06	8.83	8.83	8.45	8.59	8.13	7.93	7.45	6.99	6.97	6.72
1.99	2.55	3.04	3.79	5.84	8.36	10.94	13.38	16.33	18.72	20.67	26.05	31.23	37.53	40.32	44.05	47.43	48.51	0	0	0	0	0
0.1	0.38	0.59	0.85	1.21	1.56	1.97	2.25	2.87	3.77	4.65	5.58	5.84	6.25	7.19	7.76	8.53	9.05	8.55	9.29	10.06	8.09	8.7
-	277.23	53.81	44.37	42.91	29.11	26.46	13.98	27.73	31.25	23.20	19.97	4.66	7.13	14.97	7.94	9.89	6.19	-5.53	8.68	8.26	-19.63	7.57
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
1.64	1.64	1.64	1.81	2.27	2.36	2.4	2.52	2.59	2.77	2.77	2.97	2.97	2.97	3.11	3.12	3.12	3.12	0	0	0	0	0
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

Access the world's leading financial data and tools

Price

Price

Ticker1099.HK

ISINCNE100000FN7

WKNA0N99U

Sinopharm Group Co stock price

Price

Overview

Intraday Feature

Total Return and Relative Price Change

Interpretation and Investment

Sinopharm Group Co Stock Price History

Sinopharm Group Co Revenue, EBIT, Net Income CNE100000FN7 · A0N99U

Revenue, EBIT and Profit

Understanding Revenue, EBIT, and Income

Yearly Analysis and Comparisons

Utilizing Expectations for Investment

Investment Insights

Sinopharm Group Co Revenue, EBIT and net profit per share

Sinopharm Group Co Income Statement, Balance Sheet, Cash Flow Statement

Keystats

Revenue and Growth

Gross Margin

EBIT and EBIT Margin

Income and Growth

Shares Outstanding

Interpreting Year to Year Comparison

Expectations and Predictions

Balance Sheet

Understanding the Balance Sheet

Assets

Liabilities

Equity

Year-to-Year Analysis

Interpreting the Data

Sinopharm Group Co stock margins CNE100000FN7 · A0N99U

Margin

Understanding Gross Margin

EBIT Margin Analysis

Revenue Margin Insights

Interpreting Expectations

Comparative Analysis

Sinopharm Group Co Margin History

Sinopharm Group Co Stock Sales Revenue, EBIT, Earnings per Share CNE100000FN7 · A0N99U

Revenue, EBIT and Earnings per share

Revenue Per Share

EBIT Per Share

Income Per Share

Expected Values

Sinopharm Group Co Revenue, EBIT and net profit per share

Sinopharm Group Co business model

Sinopharm Group Co SWOT Analysis

Strengths

Weaknesses

Opportunities

Threats

The World’s Best Investors Are On Eulerpool

Sinopharm Group Co Eulerpool Fair Value

Fair Value

Understanding Fair Value

Income-Based Fair Value

Revenue-Based Fair Value

Dividend-Based Fair Value

Expectations and Forecasts

Comparative Analysis

Sinopharm Group Co historical P/E ratio, EBIT multiple, and P/S ratio

The World’s Best Investors Are On Eulerpool

Sinopharm Group Co shares outstanding CNE100000FN7 · A0N99U

Revenue, EBIT and Earnings per share

Revenue Per Share

EBIT Per Share

Income Per Share

Expected Values

Sinopharm Group Co dividend history and estimates CNE100000FN7 · A0N99U

Dividend

Dividend Overview

Interpretation and Use

Investment Strategy

Sinopharm Group Co Dividend History

Ticker
1099.HK

ISIN
CNE100000FN7

WKN
A0N99U